Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||
net income | 504,000,000 | 283,000,000 | 492,000,000 | 117,000,000 | 300,000,000 | 317,000,000 | 336,000,000 | 381,000,000 | 268,000,000 | 333,000,000 | 443,000,000 | 295,000,000 | 420,000,000 | 239,000,000 | 209,000,000 | 470,000,000 | -51,000,000 | -211,000,000 | 392,000,000 | -23,000,000 | 139,000,000 | 136,000,000 | -2,692,000,000 | 291,000,000 | 431,000,000 | 426,000,000 | 914,000,000 | 1,061,000,000 | 677,000,000 | 96,000,000 | 273,000,000 | -648,000,000 | 32,000,000 | 173,000,000 | 402,000,000 | 122,000,000 | 279,000,000 | 82,000,000 | 177,000,000 | 216,000,000 | 228,000,000 | 103,000,000 | 262,000,000 | 370,000,000 | 311,000,000 | 275,000,000 | 372,000,000 | 304,000,000 |
reconciliation of net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax | -75,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 230,000,000 | 204,000,000 | 262,000,000 | 257,000,000 | 258,000,000 | 257,000,000 | 254,000,000 | 273,000,000 | 261,000,000 | 260,000,000 | 257,000,000 | 255,000,000 | 238,000,000 | 244,000,000 | 231,000,000 | 224,000,000 | 178,000,000 | 197,000,000 | 178,000,000 | 161,000,000 | 160,000,000 | 166,000,000 | 169,000,000 | 163,000,000 | 157,000,000 | 148,000,000 | 136,000,000 | 214,000,000 | 131,000,000 | 49,000,000 | 127,000,000 | 225,000,000 | 152,000,000 | 129,000,000 | 122,000,000 | 143,000,000 | 32,000,000 | 206,000,000 | 114,000,000 | 106,000,000 | 109,000,000 | 110,000,000 | 108,000,000 | 100,000,000 | 97,000,000 | 101,000,000 | 96,000,000 | 112,000,000 |
(gains)/losses on asset sales | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax expense | 25,000,000 | -5,000,000 | 14,000,000 | -28,000,000 | 36,000,000 | 22,000,000 | 27,000,000 | 16,000,000 | 43,000,000 | -27,000,000 | 49,000,000 | 9,000,000 | -21,000,000 | 62,000,000 | -43,000,000 | 23,000,000 | 96,000,000 | 11,000,000 | 50,000,000 | 24,000,000 | 87,000,000 | 19,000,000 | 14,000,000 | 21,000,000 | ||||||||||||||||||||||||
(gain)/loss on foreign currency revaluation | 15,000,000 | 12,000,000 | -7,000,000 | -8,000,000 | 8,000,000 | -3,000,000 | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||
settlement of terminated interest rate hedging instruments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33,000,000 | 0 | 0 | 0 | 0 | 21,000,000 | -19,000,000 | |||||||||||||||||||||||||||||||||
equity earnings in unconsolidated entities | -96,000,000 | -93,000,000 | -103,000,000 | -154,000,000 | -97,000,000 | -106,000,000 | -95,000,000 | -92,000,000 | -99,000,000 | -89,000,000 | -89,000,000 | -97,000,000 | -105,000,000 | -104,000,000 | -97,000,000 | -84,000,000 | -69,000,000 | -33,000,000 | -88,000,000 | -75,000,000 | -89,000,000 | -81,000,000 | -110,000,000 | -114,000,000 | -102,000,000 | -83,000,000 | -89,000,000 | -94,000,000 | -110,000,000 | -96,000,000 | -75,000,000 | -89,000,000 | -80,000,000 | -68,000,000 | -53,000,000 | -62,000,000 | -45,000,000 | |||||||||||
distributions on earnings from unconsolidated entities | 113,000,000 | 131,000,000 | 125,000,000 | 122,000,000 | 133,000,000 | 118,000,000 | 132,000,000 | 107,000,000 | 132,000,000 | 111,000,000 | 108,000,000 | 144,000,000 | 120,000,000 | 128,000,000 | 96,000,000 | 109,000,000 | 111,000,000 | 101,000,000 | 110,000,000 | 128,000,000 | 108,000,000 | 111,000,000 | 125,000,000 | 94,000,000 | 107,000,000 | 102,000,000 | 98,000,000 | 98,000,000 | 118,000,000 | 105,000,000 | 101,000,000 | 86,000,000 | ||||||||||||||||
gain on investments in unconsolidated entities | 0 | 0 | -31,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
other | 16,000,000 | 13,000,000 | 19,000,000 | -36,000,000 | 15,000,000 | 30,000,000 | 8,000,000 | -36,000,000 | 19,000,000 | 22,000,000 | 15,000,000 | -25,000,000 | 14,000,000 | 23,000,000 | 4,000,000 | -35,000,000 | 16,000,000 | 13,000,000 | 14,000,000 | -41,000,000 | 19,000,000 | 5,000,000 | 5,000,000 | -1,000,000 | 14,000,000 | 1,000,000 | 7,000,000 | 8,000,000 | 4,000,000 | 2,000,000 | 11,000,000 | -9,000,000 | 5,000,000 | 4,000,000 | 10,000,000 | 12,000,000 | 7,000,000 | 2,000,000 | 4,000,000 | -1,000,000 | 1,000,000 | 5,000,000 | 1,000,000 | 4,000,000 | ||||
changes in assets and liabilities, net of acquisitions | 158,000,000 | 0 | -140,000,000 | 43,000,000 | -9,000,000 | -192,000,000 | -443,000,000 | 131,000,000 | 198,000,000 | 18,000,000 | 154,000,000 | -122,000,000 | -39,000,000 | -99,000,000 | 70,000,000 | -123,000,000 | -195,000,000 | 128,000,000 | -302,000,000 | -365,000,000 | 333,000,000 | -4,000,000 | 305,000,000 | 288,000,000 | 177,000,000 | 318,000,000 | 208,000,000 | -303,000,000 | 343,000,000 | 253,000,000 | ||||||||||||||||||
cash from operating activities - continuing operations | 804,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
cash from operating activities - discontinued operations | 13,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | 817,000,000 | 692,000,000 | 638,000,000 | 726,000,000 | 688,000,000 | 652,000,000 | 418,000,000 | 1,010,000,000 | 83,000,000 | 887,000,000 | 742,000,000 | 334,000,000 | 941,000,000 | 790,000,000 | 339,000,000 | 633,000,000 | 335,000,000 | 234,000,000 | 789,000,000 | 257,000,000 | 281,000,000 | 83,000,000 | 889,000,000 | 726,000,000 | 306,000,000 | 436,000,000 | 1,032,000,000 | 1,312,000,000 | 279,000,000 | 493,000,000 | 520,000,000 | 581,000,000 | 456,000,000 | 644,000,000 | 815,000,000 | 81,000,000 | 251,000,000 | -252,000,000 | 631,000,000 | 120,000,000 | 559,000,000 | -75,000,000 | 729,000,000 | 722,000,000 | 312,000,000 | 137,000,000 | 817,000,000 | 359,000,000 |
cash flows from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||
cash paid in connection with acquisitions, net of cash acquired | -184,000,000 | -57,000,000 | -624,000,000 | -104,000,000 | -33,000,000 | -20,000,000 | -91,000,000 | -136,000,000 | -81,000,000 | 0 | 0 | 0 | -2,000,000 | 0 | -308,000,000 | -3,000,000 | 0 | 2,000,000 | -1,000,000 | -27,000,000 | -1,254,000,000 | 0 | -40,000,000 | |||||||||||||||||||||||||
investments in unconsolidated entities | 0 | -1,000,000 | 0 | -3,000,000 | -5,000,000 | -9,000,000 | -15,000,000 | -4,000,000 | -11,000,000 | 1,000,000 | -1,000,000 | -3,000,000 | -16,000,000 | -7,000,000 | -36,000,000 | -35,000,000 | -75,000,000 | -72,000,000 | -167,000,000 | -147,000,000 | -157,000,000 | -108,000,000 | -134,000,000 | -125,000,000 | -168,000,000 | -84,000,000 | -176,000,000 | -40,000,000 | -60,000,000 | -106,000,000 | -127,000,000 | -123,000,000 | -130,000,000 | |||||||||||||||
additions to property, equipment and other | -185,000,000 | -119,000,000 | -191,000,000 | -166,000,000 | -157,000,000 | -139,000,000 | -157,000,000 | -155,000,000 | -137,000,000 | -145,000,000 | -122,000,000 | -143,000,000 | -122,000,000 | -89,000,000 | -101,000,000 | -79,000,000 | -75,000,000 | -85,000,000 | -97,000,000 | -132,000,000 | -134,000,000 | -227,000,000 | -245,000,000 | -262,000,000 | -277,000,000 | -362,000,000 | -280,000,000 | -450,000,000 | -460,000,000 | -458,000,000 | -266,000,000 | -246,000,000 | -229,000,000 | -274,000,000 | -275,000,000 | -304,000,000 | -586,000,000 | |||||||||||
cash paid for purchases of linefill | 0 | -10,000,000 | -7,000,000 | 0 | -5,000,000 | -3,000,000 | -13,000,000 | -4,000,000 | -5,000,000 | -15,000,000 | -9,000,000 | -21,000,000 | -39,000,000 | |||||||||||||||||||||||||||||||||||
proceeds from sales of assets | 6,000,000 | 18,000,000 | 3,000,000 | 5,000,000 | 2,000,000 | 3,000,000 | 3,000,000 | 42,000,000 | 2,000,000 | 0 | 284,000,000 | 2,000,000 | 1,000,000 | 4,000,000 | 53,000,000 | 3,000,000 | 856,000,000 | 1,000,000 | 21,000,000 | 183,000,000 | 1,000,000 | 141,000,000 | 104,000,000 | 69,000,000 | 6,000,000 | 36,000,000 | 872,000,000 | 343,000,000 | 83,000,000 | 676,000,000 | 18,000,000 | 228,000,000 | 161,000,000 | 16,000,000 | 247,000,000 | 145,000,000 | 246,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 26,000,000 | -1,000,000 | 1,000,000 | 2,000,000 | 138,000,000 | ||
other investing activities | 1,000,000 | 1,000,000 | 0 | 0 | 13,000,000 | 18,000,000 | 4,000,000 | 9,000,000 | 0 | -13,000,000 | -23,000,000 | 3,000,000 | -3,000,000 | 1,000,000 | 12,000,000 | -9,000,000 | -4,000,000 | -1,000,000 | 0 | -8,000,000 | -2,000,000 | -7,000,000 | -3,000,000 | 2,000,000 | -3,000,000 | -14,000,000 | -1,000,000 | 0 | 1,000,000 | 0 | ||||||||||||||||||
cash from investing activities - continuing operations | -363,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
cash from investing activities - discontinued operations | -45,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -408,000,000 | -274,000,000 | -819,000,000 | -264,000,000 | -193,000,000 | -438,000,000 | -42,000,000 | -81,000,000 | -175,000,000 | -108,000,000 | -27,000,000 | -208,000,000 | -248,000,000 | -610,000,000 | -398,000,000 | -389,000,000 | -549,000,000 | -429,000,000 | -629,000,000 | 322,000,000 | -285,000,000 | -221,000,000 | 393,000,000 | -309,000,000 | -163,000,000 | -1,491,000,000 | -419,000,000 | -726,000,000 | ||||||||||||||||||||
cash flows from financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||
net repayments under paa commercial paper program | 0 | 251,000,000 | -410,000,000 | -93,000,000 | -60,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from the issuance of paa senior notes | 1,248,000,000 | 0 | 998,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 1,148,000,000 | 749,000,000 | 0 | ||||||||||||||||||||||||||||||||||||
repurchase of common units by a subsidiary | 0 | 0 | 0 | -49,000,000 | -25,000,000 | -61,000,000 | -64,000,000 | |||||||||||||||||||||||||||||||||||||||||
repurchase of series a preferred units by a subsidiary | 0 | 0 | -333,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
distributions paid to class a shareholders | -75,000,000 | -75,000,000 | -75,000,000 | -63,000,000 | -63,000,000 | -62,000,000 | -63,000,000 | -53,000,000 | -52,000,000 | -52,000,000 | -52,000,000 | -42,000,000 | -43,000,000 | -42,000,000 | -35,000,000 | -35,000,000 | -35,000,000 | -35,000,000 | -35,000,000 | -34,000,000 | -33,000,000 | -33,000,000 | -66,000,000 | -66,000,000 | -60,000,000 | -57,000,000 | -48,000,000 | -47,000,000 | -48,000,000 | -47,000,000 | -47,000,000 | -46,000,000 | -84,000,000 | -84,000,000 | -57,000,000 | -55,000,000 | -51,000,000 | |||||||||||
distributions paid to noncontrolling interests | -356,000,000 | -343,000,000 | -388,000,000 | -339,000,000 | -335,000,000 | -321,000,000 | -324,000,000 | -294,000,000 | -283,000,000 | -268,000,000 | -268,000,000 | -275,000,000 | -220,000,000 | -235,000,000 | -188,000,000 | -158,000,000 | -136,000,000 | -157,000,000 | -138,000,000 | -162,000,000 | -138,000,000 | -164,000,000 | -233,000,000 | -260,000,000 | -243,000,000 | -267,000,000 | -207,000,000 | -232,000,000 | -208,000,000 | -232,000,000 | -171,000,000 | -177,000,000 | -315,000,000 | -315,000,000 | -315,000,000 | -307,000,000 | -373,000,000 | |||||||||||
contributions from noncontrolling interests | 5,000,000 | 25,000,000 | 4,000,000 | 17,000,000 | 16,000,000 | 12,000,000 | 12,000,000 | 53,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||
other financing activities | -42,000,000 | -4,000,000 | -15,000,000 | -4,000,000 | -31,000,000 | -10,000,000 | -4,000,000 | -4,000,000 | -25,000,000 | -4,000,000 | -55,000,000 | -5,000,000 | -60,000,000 | -4,000,000 | 20,000,000 | -22,000,000 | -110,000,000 | -91,000,000 | 63,000,000 | 39,000,000 | -83,000,000 | -12,000,000 | 112,000,000 | -8,000,000 | -92,000,000 | -11,000,000 | 58,000,000 | -3,000,000 | -79,000,000 | -2,000,000 | 64,000,000 | -41,000,000 | -80,000,000 | -1,000,000 | 127,000,000 | -18,000,000 | ||||||||||||
net cash provided by/(used in) financing activities | 262,000,000 | -641,000,000 | -605,000,000 | -197,000,000 | -310,000,000 | 667,000,000 | 1,281,000,000 | 259,000,000 | ||||||||||||||||||||||||||||||||||||||||
effect of translation adjustment - continuing operations | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
effect of translation adjustment - discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents and restricted cash | 721,000,000 | -56,000,000 | 78,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents and restricted cash, beginning of period | 0 | 0 | 349,000,000 | 0 | 0 | 0 | 453,000,000 | 0 | 0 | 0 | 404,000,000 | 0 | 0 | 0 | 456,000,000 | 0 | 0 | 0 | 63,000,000 | 0 | 0 | 0 | 84,000,000 | 0 | 0 | 0 | 69,000,000 | |||||||||||||||||||||
cash and cash equivalents and restricted cash, end of period | 721,000,000 | 31,000,000 | 429,000,000 | -292,000,000 | 85,000,000 | 222,000,000 | 334,000,000 | 191,000,000 | -674,000,000 | 407,000,000 | 529,000,000 | -221,000,000 | 355,000,000 | 149,000,000 | 121,000,000 | 259,000,000 | 164,000,000 | -25,000,000 | 58,000,000 | 15,000,000 | -58,000,000 | -56,000,000 | 162,000,000 | -586,000,000 | 200,000,000 | -2,000,000 | 472,000,000 | |||||||||||||||||||||
cash paid for: | ||||||||||||||||||||||||||||||||||||||||||||||||
interest, net of amounts capitalized | 81,000,000 | 126,000,000 | 90,000,000 | 112,000,000 | 59,000,000 | 116,000,000 | 64,000,000 | 130,000,000 | 59,000,000 | 123,000,000 | 65,000,000 | 125,000,000 | 67,000,000 | 127,000,000 | 74,000,000 | 136,000,000 | 63,000,000 | 137,000,000 | 65,000,000 | 143,000,000 | 72,000,000 | 148,000,000 | 65,000,000 | 134,000,000 | 75,000,000 | 118,000,000 | 70,000,000 | 119,000,000 | 78,000,000 | 127,000,000 | 76,000,000 | 161,000,000 | 73,000,000 | 160,000,000 | 92,000,000 | 139,000,000 | 92,000,000 | 143,000,000 | 88,000,000 | 110,000,000 | 100,000,000 | 118,000,000 | 77,000,000 | 99,000,000 | 79,000,000 | 85,000,000 | 81,000,000 | 78,000,000 |
income taxes, net of amounts refunded | 32,000,000 | 21,000,000 | 27,000,000 | 33,000,000 | 43,000,000 | 107,000,000 | 86,000,000 | 41,000,000 | 20,000,000 | 26,000,000 | -18,000,000 | 27,000,000 | 46,000,000 | 16,000,000 | 23,000,000 | 44,000,000 | 5,000,000 | 3,000,000 | 24,000,000 | 39,000,000 | 21,000,000 | 0 | 51,000,000 | 26,000,000 | 24,000,000 | 21,000,000 | 65,000,000 | 1,000,000 | 9,000,000 | 2,000,000 | 9,000,000 | 3,000,000 | 13,000,000 | 7,000,000 | 27,000,000 | 20,000,000 | 27,000,000 | 35,000,000 | 16,000,000 | 7,000,000 | 13,000,000 | 19,000,000 | 11,000,000 | 24,000,000 | 31,000,000 | 38,000,000 | 66,000,000 | 18,000,000 |
losses on asset sales | ||||||||||||||||||||||||||||||||||||||||||||||||
net borrowings/ | -267,000,000 | 382,000,000 | 1,000,000 | -166,000,000 | -299,000,000 | -8,000,000 | -124,000,000 | 149,000,000 | 53,000,000 | 149,000,000 | 0 | 14,000,000 | ||||||||||||||||||||||||||||||||||||
net cash from financing activities | -746,000,000 | -413,000,000 | -271,000,000 | -272,000,000 | -565,000,000 | -307,000,000 | -324,000,000 | -775,000,000 | -322,000,000 | -412,000,000 | -597,000,000 | -596,000,000 | -275,000,000 | -932,000,000 | -86,000,000 | -686,000,000 | 108,000,000 | -191,000,000 | 111,000,000 | -197,000,000 | -162,000,000 | 354,000,000 | 78,000,000 | 164,000,000 | ||||||||||||||||||||||||
gain on asset sales | -13,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax expense/ | 27,000,000 | 4,000,000 | -25,000,000 | 1,000,000 | -19,000,000 | 52,000,000 | -41,000,000 | -15,000,000 | -22,000,000 | -140,000,000 | 9,000,000 | |||||||||||||||||||||||||||||||||||||
net borrowings under paa commercial paper program | 71,000,000 | 107,000,000 | 791,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
effect of translation adjustment | -1,000,000 | -8,000,000 | 3,000,000 | -2,000,000 | -4,000,000 | -12,000,000 | 2,000,000 | -6,000,000 | -2,000,000 | 3,000,000 | -7,000,000 | 0 | 1,000,000 | 0 | 1,000,000 | -10,000,000 | -2,000,000 | 0 | -3,000,000 | |||||||||||||||||||||||||||||
net increase/(decrease) in cash and cash equivalents and restricted cash | 80,000,000 | -292,000,000 | -119,000,000 | 191,000,000 | -674,000,000 | 407,000,000 | 125,000,000 | 259,000,000 | 164,000,000 | -25,000,000 | -5,000,000 | 15,000,000 | -586,000,000 | 200,000,000 | -2,000,000 | 403,000,000 | ||||||||||||||||||||||||||||||||
equity-indexed compensation expense | 7,000,000 | 4,000,000 | 4,000,000 | 7,000,000 | 7,000,000 | 17,000,000 | 20,000,000 | 23,000,000 | 19,000,000 | 17,000,000 | 8,000,000 | 10,000,000 | 11,000,000 | 12,000,000 | 20,000,000 | 14,000,000 | 22,000,000 | 4,000,000 | 0 | -9,000,000 | 17,000,000 | 19,000,000 | 8,000,000 | 23,000,000 | 34,000,000 | 34,000,000 | 20,000,000 | |||||||||||||||||||||
gains on sales of linefill | 0 | 0 | -5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
change in fair value of preferred distribution rate reset option | 0 | 0 | 0 | -58,000,000 | -7,000,000 | 49,000,000 | 103,000,000 | 44,000,000 | -4,000,000 | -76,000,000 | 67,000,000 | 10,000,000 | 9,000,000 | -26,000,000 | -23,000,000 | 12,000,000 | ||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||||||
trade accounts receivable and other | ||||||||||||||||||||||||||||||||||||||||||||||||
inventory | ||||||||||||||||||||||||||||||||||||||||||||||||
trade accounts payable and other | ||||||||||||||||||||||||||||||||||||||||||||||||
cash received from sales of linefill | 0 | 0 | 0 | 11,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
repayments of paa senior notes | -700,000,000 | 0 | 0 | -400,000,000 | 0 | 0 | 0 | -750,000,000 | -600,000,000 | 0 | -950,000,000 | 0 | 0 | -400,000,000 | 0 | -400,000,000 | ||||||||||||||||||||||||||||||||
gain on foreign currency revaluation | ||||||||||||||||||||||||||||||||||||||||||||||||
gain on investment in unconsolidated entities | 0 | -4,000,000 | 0 | -267,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
net cash provided by/(used in) investing activities | -261,000,000 | 158,000,000 | -92,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash paid/(received) for: | ||||||||||||||||||||||||||||||||||||||||||||||||
net repayments under paa senior secured hedged inventory facility | 0 | 165,000,000 | -498,000,000 | -501,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
repayment of paa go zone term loans | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
gains on asset sales and asset impairments | 6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
loss on foreign currency revaluation | -23,000,000 | 46,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
(gains)/losses on asset sales and asset impairments | -154,000,000 | 0 | -4,000,000 | -42,000,000 | 222,000,000 | 368,000,000 | 2,000,000 | 35,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||
reconciliation of net income/(loss) to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
goodwill impairment loss | ||||||||||||||||||||||||||||||||||||||||||||||||
inventory valuation adjustments | 0 | 1,000,000 | 0 | 232,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 3,000,000 | 92,000,000 | 1,000,000 | 0 | 24,000,000 | 252,000,000 | 0 | 0 | 37,000,000 | 0 | ||||||||||||||||||||||||||||
(gains)/losses on sales of linefill | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in)/provided by investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents and restricted cash | 149,000,000 | -335,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
goodwill impairment losses | 0 | 0 | 0 | 2,515,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
sale of noncontrolling interest in a subsidiary | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax benefit | ||||||||||||||||||||||||||||||||||||||||||||||||
(gain on)/impairment of investments in unconsolidated entities | ||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for purchases of linefill and base gas | 0 | -2,000,000 | -7,000,000 | -5,000,000 | -41,000,000 | -9,000,000 | -8,000,000 | -16,000,000 | 0 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||
proceeds from paa go zone term loans | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in)/provided by financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||
equity-indexed compensation expense/ | -4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net borrowings under paa senior secured hedged inventory facility | 89,000,000 | 29,000,000 | 23,000,000 | 172,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
return of investment from unconsolidated entities | 0 | 1,000,000 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
cash received from sales of linefill and base gas | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of class a shares | 0 | 0 | 0 | 1,535,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of preferred units by a subsidiary | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of common units by a subsidiary | 0 | 0 | 0 | 129,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
effect of translation adjustment on cash | -6,000,000 | 0 | 0 | -3,000,000 | 2,000,000 | 1,000,000 | 0 | 0 | 0 | 4,000,000 | ||||||||||||||||||||||||||||||||||||||
net borrowings under paa senior unsecured revolving credit facility | -224,000,000 | 350,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities | 182,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of investment in unconsolidated entities | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
trade accounts payable and other current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||
net repayments under aap senior secured revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||
repayment of aap term loan | ||||||||||||||||||||||||||||||||||||||||||||||||
net increase/(decrease) in cash and cash equivalents | 4,000,000 | -9,000,000 | 16,000,000 | -3,000,000 | 56,000,000 | |||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 0 | 40,000,000 | 0 | 0 | 0 | 50,000,000 | 0 | 0 | 0 | 30,000,000 | 0 | 0 | 0 | 404,000,000 | 0 | 0 | 0 | 43,000,000 | 0 | |||||||||||||||||||||||||||
cash and cash equivalents, end of period | 36,000,000 | -4,000,000 | 11,000,000 | 26,000,000 | 4,000,000 | -14,000,000 | 9,000,000 | 41,000,000 | 16,000,000 | -3,000,000 | -3,000,000 | 40,000,000 | 5,000,000 | -5,000,000 | -430,000,000 | 460,000,000 | 369,000,000 | 7,000,000 | -4,000,000 | 32,000,000 | 9,000,000 | |||||||||||||||||||||||||||
net proceeds from sales of class a shares | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from sales of common units by a subsidiary | ||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -4,000,000 | 11,000,000 | -14,000,000 | -5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
distributions from unconsolidated entities | 52,000,000 | 65,000,000 | 50,000,000 | 49,000,000 | 52,000,000 | 55,000,000 | 57,000,000 | 48,000,000 | 54,000,000 | |||||||||||||||||||||||||||||||||||||||
accounts payable and other current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from aap term loan | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of series a preferred units by a subsidiary | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of series b preferred units by a subsidiary | ||||||||||||||||||||||||||||||||||||||||||||||||
cash received for sales of linefill and base gas | 0 | 1,000,000 | 12,000,000 | 11,000,000 | 15,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net borrowings under aap senior secured revolving credit facility | 10,000,000 | 0 | 34,000,000 | 1,000,000 | 23,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax (benefit)/expense | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of series a preferred units | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of common units by subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||||||
cash paid in connection with acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of series a preferred units by a subsidiary and associated embedded derivative | 1,570,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net repayments under paa senior unsecured revolving credit facility | ||||||||||||||||||||||||||||||||||||||||||||||||
net repayments under png credit agreement | ||||||||||||||||||||||||||||||||||||||||||||||||
contributions from noncontrolling interests related to the sale of common units by subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds received from initial public offering | ||||||||||||||||||||||||||||||||||||||||||||||||
distribution of proceeds received from initial public offering | ||||||||||||||||||||||||||||||||||||||||||||||||
distributions paid to members | ||||||||||||||||||||||||||||||||||||||||||||||||
gain on sales of linefill and base gas | ||||||||||||||||||||||||||||||||||||||||||||||||
investment in unconsolidated entities | -94,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the issuance of common units by subsidiaries | 0 | 0 | 1,099,000,000 | 193,000,000 | 211,000,000 | |||||||||||||||||||||||||||||||||||||||||||
costs incurred in connection with financing arrangements | ||||||||||||||||||||||||||||||||||||||||||||||||
cash received upon formation of equity-method investment | ||||||||||||||||||||||||||||||||||||||||||||||||
net borrowings/(repayments) under png credit agreement | ||||||||||||||||||||||||||||||||||||||||||||||||
contributions from noncontrolling interests related to the issuance of common units by subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||||||
equity earnings in unconsolidated entities, net of distributions | -6,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net borrowings under aap revolving credit facility | 5,000,000 | 6,000,000 | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
contributions from noncontrolling interests related to issuances of common units by subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||||||
net borrowings under png credit agreement | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the issuance of paa common units | 148,000,000 | 64,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
contributions from noncontrolling interests related to paa common unit issuances | ||||||||||||||||||||||||||||||||||||||||||||||||
settlement of terminated interest rate and foreign currency hedging instruments | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
change in restricted cash | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the issuance of png common units | 0 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
